These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 24119112)

  • 41. Bisoprolol and atenolol in essential hypertension: effects on systemic and renal hemodynamics and on ambulatory blood pressure.
    Leeman M; van de Borne P; Collart F; Vandenhoven G; Peeters L; Mélot C; Degaute JP
    J Cardiovasc Pharmacol; 1993 Dec; 22(6):785-91. PubMed ID: 7509894
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Age dependence of therapy result and risk in the treatment of arterial hypertension?
    Höffler D; Morgenstern HO
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S184-8. PubMed ID: 11527125
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Assessment of antihypertensive effect by blood pressure monitoring: applications to bisoprolol and lisinopril in a double-blind study.
    Vaïsse B; Herpin D; Asmar R; Battistella P; Zannad F; Boutelant S; Lyon A; Conte D; Denis J; Honore P; Contard S; Prost PL; Mallion JM; Poggi L
    J Cardiovasc Pharmacol; 1997 May; 29(5):612-7. PubMed ID: 9213203
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison of the new cardioselective beta-blocker nebivolol with bisoprolol in hypertension: the Nebivolol, Bisoprolol Multicenter Study (NEBIS).
    Czuriga I; Riecansky I; Bodnar J; Fulop T; Kruzsicz V; Kristof E; Edes I; ;
    Cardiovasc Drugs Ther; 2003 May; 17(3):257-63. PubMed ID: 14574084
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comparison of the effects of nadolol and bisoprolol on the isoprenaline-evoked dilatation of the dorsal hand vein in man.
    Abdelmawla AH; Langley RW; Szabadi E; Bradshaw CM
    Br J Clin Pharmacol; 2001 Jun; 51(6):583-9. PubMed ID: 11422018
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A clinical trial evaluating the 24-hour effects of bisoprolol/hydrochlorothiazide 5 mg/6.25 mg combination in patients with mild to moderate hypertension.
    Lewin AJ; Lueg MC; Targum S; Cardenas P
    Clin Cardiol; 1993 Oct; 16(10):732-6. PubMed ID: 8222387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comparison of bisoprolol to a metoprolol CR/ZOK tablet for control of heart rate and blood pressure in mild-to-moderate hypertensive patients: the CREATIVE study.
    Yang T; Jiang Y; Hao Y; Zhou S; Xu X; Qu B; Lin X; Ma T
    Hypertens Res; 2017 Jan; 40(1):79-86. PubMed ID: 27534738
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Beta-blockers vs. angiotensin-converting enzyme inhibitors in hypertension: effects on left ventricular hypertrophy.
    Gosse P; Roudaut R; Herrero G; Dallocchio M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S145-50. PubMed ID: 11527119
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Bisoprolol in the treatment of hypertension].
    Spinar J; Zicha J; Vítovec J
    Vnitr Lek; 1993 Sep; 39(9):865-70. PubMed ID: 8212640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A twelve-week, multicenter, randomized, double-blind, parallel-group, noninferiority trial of the antihypertensive efficacy and tolerability of imidapril and candesartan in adult patients with mild to moderate essential hypertension: the Iberian Multicenter Imidapril Study on Hypertension (IMISH).
    Palma Gámiz JL; Pêgo M; Contreras EM; Anglada MP; Martínez JO; Esquerra EA; Sagastagoitia Gorostiza JD;
    Clin Ther; 2006 Dec; 28(12):2040-51. PubMed ID: 17296460
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The Fixed Combination of Amlodipine and Bisoprolol Eliminates the Effect of -Blockers on Central Pulse Wave in Patients With Arterial Hypertension].
    Kobalava ZD; Kotovskaya YV; Bogomaz AV
    Kardiologiia; 2015 Dec; 55(12):11-16. PubMed ID: 28294759
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Efficacy and tolerability of tasosartan, a novel angiotensin II receptor blocker: results from a 10-week, double-blind, placebo-controlled, dose-titration study. Tasosartan Investigators Group.
    Neutel JM; Buckalew V; Chrysant SG; Mroczek WJ; Ruff DA; Weber M
    Am Heart J; 1999 Jan; 137(1):118-25. PubMed ID: 9878944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Switching therapy from intravenous beta blocker to bisoprolol transdermal patch for atrial fibrillation tachycardia.
    Nakamura K; Inokuchi R; Hiruma T; Tokunaga K; Doi K; Nakajima S
    J Anesth; 2016 Oct; 30(5):891-4. PubMed ID: 27262288
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Evaluation of the dose--response relationship of aliskiren, a direct renin inhibitor, in an 8-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled study in adult patients with stage 1 or 2 essential hypertension.
    Puig JG; Schunkert H; Taylor AA; Boye S; Jin J; Keefe DL
    Clin Ther; 2009 Dec; 31(12):2839-50. PubMed ID: 20110023
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of bisoprolol with nifedipine for treatment of essential hypertension in the elderly: comparative double-blind trial.
    Amabile G; Serradimigni A
    Eur Heart J; 1987 Dec; 8 Suppl M():65-9. PubMed ID: 2967187
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heart rate-reducing effects of bisoprolol in Japanese patients with chronic atrial fibrillation: results of the MAIN-AF study.
    Yamashita T; Inoue H
    J Cardiol; 2013 Jul; 62(1):50-7. PubMed ID: 23611172
    [TBL] [Abstract][Full Text] [Related]  

  • 57. An attempt at administering a transdermal formulation of bisoprolol in patients with acute cardiac symptoms.
    Nozaki A; Kobayashi T; Naruhashi K; Okugawa H; Horiuchi N; Nakanishi H; Kobayashi Y; Nakamura S
    Am J Emerg Med; 2021 Jan; 39():146-150. PubMed ID: 33039223
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical results with bisoprolol 2.5 mg/hydrochlorothiazide 6.25 mg combination in systolic hypertension in the elderly.
    Benetos A; Adamopoulos C; Argyriadis P; Bean K; Consoli S; Safar M
    J Hypertens Suppl; 2002 Feb; 20(1):S21-5. PubMed ID: 11996196
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Influence of different bisoprolol doses on hemodynamics, plasma catecholamines, platelet aggregation, and alpha 2- and beta-receptors in hypertensive patients.
    Kirsten R; Neff J; Heintz B; Nemeth N; Rahlfs VW; Nelson K
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S113-21. PubMed ID: 2439781
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Assessment of a novel transdermal selective β1-blocker, the bisoprolol patch, for treating frequent premature ventricular contractions in patients without structural heart disease.
    Shinohara M; Fujino T; Koike H; Kitahara K; Kinoshita T; Yuzawa H; Suzuki T; Fukunaga S; Kobayashi K; Aoki J; Tanabe K; Ikeda T
    J Cardiol; 2017 Sep; 70(3):212-219. PubMed ID: 28343798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.